Daniel Menold

2018

In 2018, Daniel Menold earned a total compensation of $857.3K as Vice President, Finance at Cymabay Therapeutics.

Compensation breakdown

Bonus$92,624
Option Awards$504,869
Salary$257,290
Other$2,479
Total$857,262

Menold received $504.9K in option awards, accounting for 59% of the total pay in 2018.

Menold also received $92.6K in bonus, $257.3K in salary and $2.5K in other compensation.

Rankings

In 2018, Daniel Menold's compensation ranked 9,892nd out of 14,244 executives tracked by ExecPay. In other words, Menold earned more than 30.6% of executives.

ClassificationRankingPercentile
All
9,892
out of 14,244
31st
Division
Manufacturing
3,996
out of 5,765
31st
Major group
Chemicals And Allied Products
1,501
out of 2,128
30th
Industry group
Drugs
1,266
out of 1,817
30th
Industry
Pharmaceutical Preparations
973
out of 1,391
30th
Source: SEC filing on April 26, 2019.

Menold's colleagues

We found four more compensation records of executives who worked with Daniel Menold at Cymabay Therapeutics in 2018.

2018

Paul Quinlan

Cymabay Therapeutics

General Counsel

2018

Sujal Shah

Cymabay Therapeutics

Chief Executive Officer

2018

Charles McWherter

Cymabay Therapeutics

Chief Scientific Officer

2018

Pol Boudes

Cymabay Therapeutics

Chief Medical Officer

News

In-depth

You may also like